Stock Track | Vericel Soars 8.47% Pre-market on Stellar Q3 Results, Beating Revenue and EPS Estimates

Stock Track11-06

Vericel Corporation (NASDAQ: VCEL) saw its stock price surge 8.47% in pre-market trading following the release of its impressive third-quarter 2025 financial results. The company significantly outperformed market expectations, demonstrating strong growth and profitability across key metrics.

The biotechnology firm reported Q3 revenue of $67.503 million, handily beating the IBES estimate of $64.6 million. Earnings per share (EPS) came in at $0.10, surpassing the anticipated loss of $0.01 per share. This stellar performance was underpinned by a robust gross profit of $49.585 million and an impressive gross margin of 73.5%.

Vericel's profitability metrics were equally strong, with net income reaching $5.074 million and adjusted EBITDA hitting $16.996 million, representing a 25% margin. Looking ahead, the company provided an optimistic full-year revenue outlook of $272-276 million, further boosting investor confidence. The combination of better-than-expected results and positive future guidance appears to be driving the significant pre-market rally in Vericel's stock price.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1140405223?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-06 20:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1140405223","market":"sg","top_or_hot":-1,"title":"Stock Track | Vericel Soars 8.47% Pre-market on Stellar Q3 Results, Beating Revenue and EPS Estimates","media":"Stock Track","content":"<p>Vericel Corporation (NASDAQ: VCEL) saw its stock price surge 8.47% in pre-market trading following the release of its impressive third-quarter 2025 financial results. The company significantly outperformed market expectations, demonstrating strong growth and profitability across key metrics.</p>\n\n<p>The biotechnology firm reported Q3 revenue of $67.503 million, handily beating the IBES estimate of $64.6 million. Earnings per share (EPS) came in at $0.10, surpassing the anticipated loss of $0.01 per share. This stellar performance was underpinned by a robust gross profit of $49.585 million and an impressive gross margin of 73.5%.</p>\n\n<p>Vericel's profitability metrics were equally strong, with net income reaching $5.074 million and adjusted EBITDA hitting $16.996 million, representing a 25% margin. Looking ahead, the company provided an optimistic full-year revenue outlook of $272-276 million, further boosting investor confidence. The combination of better-than-expected results and positive future guidance appears to be driving the significant pre-market rally in Vericel's stock price.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Vericel Soars 8.47% Pre-market on Stellar Q3 Results, Beating Revenue and EPS Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Vericel Soars 8.47% Pre-market on Stellar Q3 Results, Beating Revenue and EPS Estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-06 20:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vericel Corporation (NASDAQ: VCEL) saw its stock price surge 8.47% in pre-market trading following the release of its impressive third-quarter 2025 financial results. The company significantly outperformed market expectations, demonstrating strong growth and profitability across key metrics.</p>\n\n<p>The biotechnology firm reported Q3 revenue of $67.503 million, handily beating the IBES estimate of $64.6 million. Earnings per share (EPS) came in at $0.10, surpassing the anticipated loss of $0.01 per share. This stellar performance was underpinned by a robust gross profit of $49.585 million and an impressive gross margin of 73.5%.</p>\n\n<p>Vericel's profitability metrics were equally strong, with net income reaching $5.074 million and adjusted EBITDA hitting $16.996 million, representing a 25% margin. Looking ahead, the company provided an optimistic full-year revenue outlook of $272-276 million, further boosting investor confidence. The combination of better-than-expected results and positive future guidance appears to be driving the significant pre-market rally in Vericel's stock price.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VCEL","symbol_name":"Vericel Corporation","start_time":0,"source_url":"","article_id":"1140405223","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1140405223","pubTimestamp":1762433901,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Vericel Corporation (NASDAQ: VCEL) saw its stock price surge 8.47% in pre-market trading following the release of its impressive third-quarter 2025 financial results. The company significantly...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VCEL":"Vericel Corporation"},"translate_title":"股票追踪|Vericel盘前飙升8.47%，第三季度业绩出色，营收和每股收益超出预期","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VCEL":1},"content_text":"Vericel Corporation (NASDAQ: VCEL) saw its stock price surge 8.47% in pre-market trading following the release of its impressive third-quarter 2025 financial results. The company significantly outperformed market expectations, demonstrating strong growth and profitability across key metrics.\nThe biotechnology firm reported Q3 revenue of $67.503 million, handily beating the IBES estimate of $64.6 million. Earnings per share (EPS) came in at $0.10, surpassing the anticipated loss of $0.01 per share. This stellar performance was underpinned by a robust gross profit of $49.585 million and an impressive gross margin of 73.5%.\nVericel's profitability metrics were equally strong, with net income reaching $5.074 million and adjusted EBITDA hitting $16.996 million, representing a 25% margin. Looking ahead, the company provided an optimistic full-year revenue outlook of $272-276 million, further boosting investor confidence. The combination of better-than-expected results and positive future guidance appears to be driving the significant pre-market rally in Vericel's stock price.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1140405223","isCrawlerRequest":true}